Indraprastha Medical Reports Q2 Revenue of ₹412 Crore Versus ₹380 Crore YoY

Market snapshot: Indraprastha Medical Corporation Limited reported a steady increase in its Q2 topline performance. Revenue for the quarter rose to ₹412 crore compared to ₹380 crore in the corresponding period of the previous financial year.

Data Snapshot

• Q2 revenue reached ₹412 crore compared to ₹380 crore in Q2 of the previous fiscal year.

What's Changed

• Topline revenue expanded by ₹32 crore YoY in Q2, representing an 8.42% growth rate.

Key Takeaways

• Indraprastha Medical Corporation delivered sustained topline growth with Q2 revenue coming in at ₹412 crore.
• Year-over-year revenue comparison reflects stable patient footfall and strong bed utilization across core specialties.
• The performance builds on steady operational momentum seen throughout the first half of the fiscal year.

SAHI Perspective

The 8.42% year-over-year growth in quarterly revenue demonstrates consistent demand for acute tertiary healthcare services. Steady topline momentum indicates resilient healthcare delivery operations and stable average revenue per occupied bed.

Market Implications

Positive operational performance reinforces steady earnings visibility for hospital operators, supporting healthcare sector sentiment amid structural demand for specialty medical services.

Trading Signals

Market Bias: Bullish

Topline revenue expansion to ₹412 crore from ₹380 crore YoY indicates healthy demand fundamentals in tertiary hospital operations.

Overweight: Healthcare Services, Hospitals

Trigger Factors:

• Bed occupancy rate shifts across key hospital units
• Average Revenue Per Occupied Bed (ARPOB) realizations

Time Horizon: Near-term (0-3 months)

Industry Context

Tertiary hospital operators in metro markets benefit from strong clinical capabilities, rising insurance penetration, and persistent demand for complex surgeries and specialty care.

Key Risks to Watch

• Inflationary pressures on clinical supply and personnel costs
• Regulatory policy updates regarding price caps on procedures or essential devices

Recent Developments

In Q1 FY27, Indraprastha Medical Corporation reported consolidated revenue of ₹406.15 crore and net profit of ₹55.85 crore.

Closing Insight

Continued topline expansion underscores the stability of healthcare demand and strong execution in Indraprastha Medical's core multi-specialty operations.

High Performance Trading with SAHI.